openPR Logo
Press release

Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipients Propels Growth

Albumin Market: Substantial Use of Human Serum Albumin as

Albumin Market: Snapshot

Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally.

At the forefront of driving growth in the global albumin market is the enhanced stability of products such as vaccines containing albumin as an excipient. Apart from this, the enhancement in molecular separation and protein purification technologies, coupled with rising use of recombinant albumin, is expected to fuel the global albumin market significantly over the forecast period.

Request Sample Copy of the Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3984

On the flipside, however, strict rules pertaining to the use of albumin, their expensiveness, and concerns about their impact on human health are posing a roadblock to the market.

A report by Transparency Market Research predicts the global human albumin market to become worth US$10.359 bn by 2025 from US$4.8 bn in 2016 by clocking a CAGR of 9.2% from 2017 to 2025.

Demand for Blood Volumizer from Emerging Economies Makes Blood Human Serum Albumin Leading Segment

Based on the types of product, the global albumin market can be classified into bovine serum albumin (BSA) extracted from fetal bovine serum, human serum albumin (HSA ) which is extracted from human plasma, and recombinant albumin produced from recombinant yeast, rice and other culture sources. Among them, the human serum albumin segment holds maximum share and going forward is expected to rise at a robust CAGR of 9.2% from 2017 to 2025. This is because, human serum albumin finds widespread application as a blood volumizer in case of burns, shocks, and other rare diseases. Demand for blood volumizer from emerging markets like China, India, and Brazil is expected to fuel this growth over the forecast period.

Request Brochure Copy of the Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3984

The recombinant albumin segment is projected to expand at a CAGR of 6.0% from 2017 to 2025. It finds widespread application in drug formulation, drug delivery, diagnostics, and in many of the life sciences procedures. Bovine serum albumin market is expected to grow at CAGR of 2.6% during forecast period. It mainly finds application as a major component of cell and microbial culture media. High demand of recombinant albumin and bovine serum albumin as an excipient in drug delivery and vaccine production is expected to drive demand for these segments in the foreseeable future.

China and India Majorly Fuelling Growth in Asia Pacific Market

Geographically, the key segments of the global albumin market are North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. Asia Pacific, of them, dominates the market with a leading share and going forward is expected rise at a robust 11.5% CAGR, powered primarily by the emerging markets in India and China. A large pool of elderly and rising instances of rare diseases, burns and surgeries are said to be catalyzing growth in the region.

Request For Discount On This Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3984

In the years ahead, however, North America and Europe are projected to lose their market share because of the rise in preference for albumin alternatives and ambiguity in use of albumin as proven blood volumizer.

Some of the key players operating in the global albumin market are Medxbio Pte. Ltd.CSL Behring LLC, Grifols International, S.A., Octapharma AG, Kedrion S.p.A., Baxalta Inc., Octapharma AG, InVitria, Kedrion S.p.A., Mitsubishi Tanabe Pharma Corporation, Albumedix A/S, Sigma-Aldrich Co. LLC. (Merck KGaA), Thermo Fisher Scientific, Inc., and HiMedia Laboratories Pvt. Ltd.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipients Propels Growth here

News-ID: 1057034 • Views: 396

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Albumin

Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Albumin Market, Growing $10,305 Million By 2023
Albumin is globular protein found in blood plasma. Serum albumin is the most abundant plasma protein, constituting around 50% of human plasma protein. Albumin is obtained from plasma fractionation process where human serum albumin and bovine serum albumin is most widely used. Recombinant albumin is produced using recombinant techniques in rice plants, yeast species, and other cell lines. Albumin is used as blood volumizer and is employed in the treatment
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated